Medication Treatment & the Importance of Individualized Case Plans
This series is presented free of charge for qualifying judges.
0
Days & Times
9 a.m. Hawaii / 10 a.m. Alaska / 11 a.m. Pacific / 12 p.m. Mountain / 1 p.m. Central / 2 p.m. Eastern
Duration: 60 minutes
Course Location
Online
Course Fees
This series is presented free of charge for qualifying judges.
$0
Without them, people with OUD are at high risk of death. However, each medication comes with different physical properties and federal regulations that influence client care plans. Using case examples, this webinar will compare, contrast, and provide the scientific evidence for each of the three FDA-approved medications for OUD. Additionally, the session will focus on the importance of communication and collaboration between the healthcare and judicial systems to build individualized plans for clients.
Presented by Hon. Shaun Floerke & Dr. Ellen Edens
This series is presented free of charge for qualifying judges. $0
During this course, you will learn to:
- Differentiate between physiologic dependence and a substance use disorder;
- Compare and contrast three medications to treat OUD, including regulations and monitoring requirements, and apply this knowledge to case examples; and
- Conceptualize how individual treatment plans and client-centered conversations can aid client engagement and improve outcomes in both healthcare and justice settings.
Opioid Use Disorder and the Courts: Protecting Children & Supporting Families
A Five-Part Webinar Series for Judges
Beginning December 1, 2020 / Time: 11:00 a.m. Pacific / Duration: 60 minutes
In addition to the impact of opioid abuse on criminal courts, the nation’s family and juvenile courts are also being deeply impacted by the opioid crisis. This series of five 60-minute webinars will educate judges on identification & early intervention strategies in cases that involve children of parents with opioid abuse disorder as well as identify techniques for judges presiding over such cases to combat secondary trauma, which can lead to implicit bias.
This webinar series is being presented through generous funding from the State Justice Institute (SJI) in conjunction with The National Judicial College (NJC).
Without them, people with OUD are at high risk of death. However, each medication comes with different physical properties and federal regulations that influence client care plans. Using case examples, this webinar will compare, contrast, and provide the scientific evidence for each of the three FDA-approved medications for OUD. Additionally, the session will focus on the importance of communication and collaboration between the healthcare and judicial systems to build individualized plans for clients.
Presented by Hon. Shaun Floerke & Dr. Ellen Edens